University Logo University of Dundee Tay Bridge Picture

TCGP Image

Asthma Research Unit Posters

Tayside Centre for General PracticeAsthma Research Unit
Research Button
Staff Button
Publications Button
Links Button



Medinex Link

 

Assessing the management and associated
cost of paediatric asthma in the community

Presented at the
National Asthma Campaign Conference
June 1999 in London

Hoskins G, McCowan C, Nevile R G,
Smith B, Thomas G E, Silverman S


Aim

To assess the impact of poorly controlled asthma on overall healthcare by comparing resource use of those children less than 12 years who suffer ‘attacks’ with those who do not.

Method

Two identical studies involved the audit of asthma management within a general practice setting. 393 practices from throughout the United Kingdom provided details of health service resource use over a retrospective 12 month period for 30 (minimum) patients randomly selected from the practice active asthma register. This provided a data set on the management of 2,770 patients under the age of 12 years (61% male) with asthma. All patients were invited for a clinical assessment. The database was utilised to determine whether usage of health service resource related to asthma control. Published unit cost data was then used to construct cost estimates for different management options. By pricing each individual item of resource use as in table 2, patient costs were calculated. The mean management costs, including confidence intervals, of patients who had experienced an asthma attack were compared with those who had not.

Resource use for those who did & did not have an attack

Table 1

Attack
n=707

No Attack
n=2063

Number of:

Patient initiated GP consultations

2006 2543

Patient initiated nurse consultations

241 471

Practice GP reviews

704 931

Practice Nurse reviews

1119 2593

Number of patients given:

Systemic steroids

421(60%) 68(3%)

Emergency bronchodilators

265(37%) 22(1%)

Prophylactic Medication

651(92%) 1424(69%)

Number of patients who attended:

Accident & Emergency (ER)

110(16%) 21(1%)

Hospital Admission

124(18%) 12(1%)

Outpatients

119(17%) 111(5%)

Breakdown of healthcare costs comparing the attack group with those who did not have an attack

Table 2

Costs per patient (£)

Cost

Total cost (£)

Had an Attack
(n=707)

95% confidence interval

Had no attack
(n=2063)

95% confidence
interval

Patient initiated GP consultations 40 941 25.54 23.99 to 27.09 11.09 10.44 to 11.74
Practice initiated GP consultations 22 890 13.94 12.18 to 15.71 6.32 5.72 to 6.91
Patient initiated nurse consultations 4 272 2.05 1.68 to 2.40 1.37 1.18 to 1.56
Nurse review 22 272 9.50 8.63 to 10.36 7.54 7.15 to 7.93
Systemic steroids 702 0.87 0.79 to 0.94 0.04 0.03 to 0.06
Emergency bronchodilators 121 0.16 0.14 to 0.19 0.003 0.0017 to 0.0042
Drugs 173 592 90.41 80.86 to 99.96 53.16 49.25 to 57.07
A&E (ER) visits 9 978 12.27 9.42 to 15.11 0.63 0.34 to 0.93
Hospital stay 108 349 140.12 105.86 to 174.38 4.50 1.44 to 7.56
Outpatients 42 264 34.91 25.56 to 44.25 8.52 6.74 to 10.31
Total 425 381 329.77 286.91 to 372.59 93.17 87.32 to 99.06

Conclusion

The average annual cost of treating children with unstable asthma is £329.77 compared to £93.17 for those who are more controlled. 55% of the total cost was attributed to the 26% of children who experienced an asthma attack. 42% of this group’s expenditure was due to hospital admission. The cost of emergency drugs used to treat attacks represented a negligible cost when compared with the cost of hospital stay. Treating more of the hospitalised children within general practice will greatly reduce costs. The high cost of managing children who have had an attack highlights the importance of prevention. Given the major burden associated with uncontrolled asthma, appropriate targeting of preventative measures and ensuring good compliance, could reduce overall healthcare costs and growing pressures on hospital services associated with management of asthma.

This study was supported by a grant from Zeneca Pharmaceuticals.



For further information on the Asthma Research Unit, please contact:
Tayside Centre for General Practice
University of Dundee
Kirsty Semple Way
Dundee DD2 4BF
Scotland
Tel : +44 (0)1382 420000
Fax :+44 (0)1382 420010

aru@tcgp.dundee.ac.uk

Updated by Mark Stewart: Tuesday, November 6, 2001